[HTML][HTML] Significance of levocarnitine treatment in dialysis patients
H Takashima, T Maruyama, M Abe - Nutrients, 2021 - mdpi.com
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
[PDF][PDF] Significance of Levocarnitine Treatment in Dialysis Patients. Nutrients 2021, 13, 1219
H Takashima, T Maruyama, M Abe - Extension of Healthy Life Span of …, 2021 - core.ac.uk
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
Significance of Levocarnitine Treatment in Dialysis Patients.
H Takashima, T Maruyama, M Abe, P Khosla - Nutrients, 2021 - search.ebscohost.com
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
Significance of Levocarnitine Treatment in Dialysis Patients.
H Takashima, T Maruyama, M Abe - Nutrients, 2021 - europepmc.org
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
Significance of Levocarnitine Treatment in Dialysis Patients
H Takashima, T Maruyama - Nutrients, 2021 - search.proquest.com
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
Significance of levocarnitine treatment in dialysis patients.
H Takashima, T Maruyama, M Abe - 2021 - cabidigitallibrary.org
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
[PDF][PDF] Significance of Levocarnitine Treatment in Dialysis Patients. Nutrients 2021, 13, 1219
H Takashima, T Maruyama, M Abe - 2021 - pdfs.semanticscholar.org
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
Significance of Levocarnitine Treatment in Dialysis Patients
H Takashima, T Maruyama, M Abe - Nutrients, 2021 - pubmed.ncbi.nlm.nih.gov
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
Significance of Levocarnitine Treatment in Dialysis Patients
H Takashima, T Maruyama, M Abe - 2021 - agris.fao.org
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
[HTML][HTML] Significance of Levocarnitine Treatment in Dialysis Patients
H Takashima, T Maruyama, M Abe - Nutrients, 2021 - ncbi.nlm.nih.gov
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …